Canopy Growth (CGC) Accumulated Expenses (2019 - 2026)
Canopy Growth (CGC) posted Accumulated Expenses of $11.4 million for Q1 2026, up 25.54% sequentially from $9.1 million in Q4 2025, and up 19.36% YoY from $9.6 million in Q1 2025.
Canopy Growth (CGC) Accumulated Expenses (2019 - 2026) Analysis & Trends
Canopy Growth has reported Accumulated Expenses for 8 years, with the latest figure at $11.4 million in Q1 2026.
- Quarterly Accumulated Expenses rose 19.36% year-over-year to $11.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.4 million (up 19.36% YoY) and the FY2026 annual result came in at $11.4 million, up 19.36% from the prior year.
- Accumulated Expenses climbed to $11.4 million in Q1 2026 per CGC's latest filing, from $9.1 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $59.4 million in Q1 2022 and troughed at $7.7 million in Q4 2024.
- A 5-year average of $23.9 million and a median of $15.8 million in 2024 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses soared 275.56% in 2023, then sank 77.31% in 2024.
- Over 5 years, Accumulated Expenses stood at $21.5 million in 2022, then slumped by 41.48% to $12.6 million in 2023, then plunged by 38.49% to $7.7 million in 2024, then gained by 17.43% to $9.1 million in 2025, then rose by 25.54% to $11.4 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $11.4 million, $9.1 million, and $28.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Canopy Growth | 437.04 Mn | 190.03 Mn | 16.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.06 Mn |
| Mar 31, 2026 | 11.42 Mn |
| Dec 31, 2025 | 9.10 Mn |
| Sep 30, 2025 | 28.65 Mn |
| Jun 30, 2025 | 11.74 Mn |
| Mar 31, 2025 | 9.57 Mn |
| Dec 31, 2024 | 7.75 Mn |
| Sep 30, 2024 | 8.75 Mn |
| Jun 30, 2024 | 15.83 Mn |
| Mar 31, 2024 | 40.10 Mn |
| Dec 31, 2023 | 12.60 Mn |
| Sep 30, 2023 | 38.54 Mn |
| Jun 30, 2023 | 56.15 Mn |
| Mar 31, 2023 | 39.75 Mn |
| Dec 31, 2022 | 21.52 Mn |
| Sep 30, 2022 | 20.14 Mn |
| Jun 30, 2022 | 14.95 Mn |
| Mar 31, 2022 | 59.43 Mn |
| Dec 31, 2021 | 17.90 Mn |
| Sep 30, 2021 | 68.38 Mn |